Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2005;106:1156-1158
© 2005 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trukhacheva, E.
Right arrow Articles by Lakkis, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trukhacheva, E.
Right arrow Articles by Lakkis, N.
Related Collections
Right arrow Critical Care
Right arrow Imaging
Right arrow Medical complications of pregnancy

CASE REPORTS

Massive Pulmonary Embolism in Pregnancy Treated With Tissue Plasminogen Activator

Elena Trukhacheva, MD1, Michael Scharff, MD1, Michael Gardner, MD, MPH2 and Nasser Lakkis, MD3

From the 1Department of Obstetrics and Gynecology, Baylor College of Medicine; 2Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine; and 3Division of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.

BACKGROUND: Systemic thrombolysis with tissue plasminogen activator (t-PA) in pregnancy is still considered an experimental treatment. Several reports have described the successful use of t-PA in the setting of hemodynamic instability in gravidas with massive pulmonary emboli.

CASE: A 34-year-old woman received a diagnosis of severe pulmonary embolism at 23 weeks of gestation. She developed pulmonary hypertension and became hemodynamically unstable. Thrombolytic therapy using t-PA was administered. The patient tolerated thrombolysis well and delivered at term. No placental abnormalities were identified on ultrasonogram or after delivery. The patient was also found to be a heterozygous carrier of prothrombin G20210A mutation.

CONCLUSION: We describe the successful thrombolysis with t-PA of a massive, life-threatening pulmonary embolism without complications followed by a term delivery.




This article has been cited by other articles:


Home page
StrokeHome page
J. De Keyser, Z. Gdovinova, M. Uyttenboogaart, P. C. Vroomen, and G. J. Luijckx
Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations
Stroke, September 1, 2007; 38(9): 2612 - 2618.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Obstetricians and Gynecologists.